» Articles » PMID: 30787416

T Lymphocytes in the Intestinal Mucosa: Defense and Tolerance

Overview
Date 2019 Feb 22
PMID 30787416
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Although lymphocytes are known to circulate throughout lymphoid tissues and blood, they also establish residency in nonlymphoid organs, most prominently in barrier tissues, such as the intestines. The adaptation of T lymphocytes to intestinal environments requires constant discrimination between natural stimulation from commensal flora and food and pathogens that need to be cleared. Genetic variations that cause a defective defense or a break in tolerance along with environmental cues, such as infection or imbalances in the gut microbiota known as dysbiosis, can trigger several immune disorders via the activation of T lymphocytes in the intestines. Elucidation of the immune mechanisms that distinguish between commensal flora and pathogenic organisms may reveal therapeutic targets for the prevention or modulation of inflammatory diseases and boost the efficacy of cancer immunotherapy. In this review, we discuss the development and adaptation of T lymphocytes in the intestine, how these cells protect the host against pathogenic infections while tolerating food antigens and commensal microbiota, and the potential implications of targeting these cells for disease management and therapeutics.

Citing Articles

The gut-brain axis and pain signalling mechanisms in the gastrointestinal tract.

Meerschaert K, Chiu I Nat Rev Gastroenterol Hepatol. 2024; 22(3):206-221.

PMID: 39578592 DOI: 10.1038/s41575-024-01017-9.


Vitamin C-Dependent Uptake of Non-Heme Iron by Enterocytes, Its Impact on Erythropoiesis and Redox Capacity of Human Erythrocytes.

Pan X, Koberle M, Ghashghaeinia M Antioxidants (Basel). 2024; 13(8).

PMID: 39199214 PMC: 11352176. DOI: 10.3390/antiox13080968.


Machine-learning-based integrative -'omics analyses reveal immunologic and metabolic dysregulation in environmental enteric dysfunction.

Zulqarnain F, Zhao X, Setchell K, Sharma Y, Fernandes P, Srivastava S iScience. 2024; 27(6):110013.

PMID: 38868190 PMC: 11167436. DOI: 10.1016/j.isci.2024.110013.


Propionic acid ameliorates cognitive function through immunomodulatory effects on Th17 cells in perioperative neurocognitive disorders.

Dai H, Zhang Z, Tan C, Xian X, Ji D, Yang J Heliyon. 2024; 10(8):e28817.

PMID: 38699705 PMC: 11063405. DOI: 10.1016/j.heliyon.2024.e28817.


Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming.

Jones J, Shi Q, Nath R, Brito I PLoS One. 2024; 19(2):e0297897.

PMID: 38363784 PMC: 10871517. DOI: 10.1371/journal.pone.0297897.


References
1.
Hanninen A, Salmi M, Simell O, Jalkanen S . Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes. 1996; 45(9):1173-80. DOI: 10.2337/diab.45.9.1173. View

2.
Gopalakrishnan V, Spencer C, Nezi L, Reuben A, Andrews M, Karpinets T . Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2017; 359(6371):97-103. PMC: 5827966. DOI: 10.1126/science.aan4236. View

3.
Routy B, Le Chatelier E, Derosa L, Duong C, Alou M, Daillere R . Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2017; 359(6371):91-97. DOI: 10.1126/science.aan3706. View

4.
Starr T, Jameson S, Hogquist K . Positive and negative selection of T cells. Annu Rev Immunol. 2002; 21:139-76. DOI: 10.1146/annurev.immunol.21.120601.141107. View

5.
Bai L, Peng H . Generating CD8αα IELs from two sources of thymic precursors. Cell Mol Immunol. 2017; 15(6):640-641. PMC: 6078981. DOI: 10.1038/cmi.2017.93. View